companies

Oncomfort

Founded 2015
Employees 20+
Primary contact
Chaussée de Louvain 172
1300 Wavre
Belgium
+32 (0)800 32 870
Links
https://www.oncomfort.com/en
Diseases & Conditions
Sections
Technologies
Oncomfort has developed a digital sedation solution for relieving patients' pain and anxiety before, during and after medical procedures. Called SedaKit, it combines clinical hypnotherapy and integrative therapeutic techniques through Virtual Reality. The VR-enabled digital therapy modules are available in 12 different languages and are intended for patients aged six or more. According to the company, Sedation optimizes the use of hospital infrastructure while reducing costs and improving the quality of care.
Select partners: CHIREC Brussels Hospital, Assistance Publique - Hôpitaux de Paris, Giga Consciousness laboratory.
Founded 2015
Employees 20+
Primary contact
Chaussée de Louvain 172
1300 Wavre
Belgium
+32 (0)800 32 870
Links
https://www.oncomfort.com/en
Diseases & Conditions
Sections
Technologies

Funding 💰

Total $14.7M
Select investors Crédit Mutuel Innovation, Debiopharm Innovation Fund, Wallonia Innovation and Growth, Be Angels, BAN Vlaanderen

Key people 🧑‍🤝‍🧑

Highlights ⭐

  • It works: Oncomfort's Digital Sedation has been used by more than 75,000 patients in over 100 hospitals. Also, it has been tested in 25+ studies. 🔗
  • A drug-free solution: Oncomfort Digital Sedation allows significant reduction of the use of opioids and pharmacological sedatives. It has been found to be 49% more adequate sedation than midazolam, with zero side effects or adverse events reported 🔗
  • Portable and easy-to-use: The Oncomfort Sedakit is an all-in-one portable solution that makes Digital Sedation simple, easy and accessible for both adults and children in a wide range of medical interventions.
  • Used in a range of procedures: anaesthesiology, interventional cardiology, interventional radiology, ObGyn, oncology pain management, paediatrics, surgery, dentistry emergency, geriatrics, urology, burn unit.

Video ▶️

Awards & Recognitions 🏆

  • 2021 Deloitte Most disruptive Innovator
  • 2021 Medtech Innovator: Top 50 Medtech Startups
  • 2021 Future Unicorn Award: Nominee
  • 2020 Digital Wallonia Start-up of the Year
  • 2019 Digital Wallonia International Award

Quotes 💬

“
We are delighted to find a scientifically validated digital tool to support the overall journey of patients, which frequently includes various levels of pain, anxiety, and fear. The fact that advanced Virtual Reality in combination with hypnotherapy and integrative therapeutic techniques can be used to effectively sedate patients is truly impressive and offers an interesting option for patients to find physical and emotional relief.
— Thierry Mauvernay, President of Debiopharm 🔗
“
Our investment in Oncomfort's digital sedation solution is based on the strong potential of digital therapeutics as well as the specific intellectual property and scientific evidence that Oncomfort has built over recent years.
— Karine Lignel, CEO of Crédit Mutuel Innovation 🔗
“
With this investment in Oncomfort, we want to push the boundaries to inspire healthcare stakeholders to acknowledge that there is much more we can do for patients through digital technology.
— Tanja Dowe, CEO of Debiopharm Innovation Fund 🔗
Last update: August 16, 2022